Nanobiotix CEO Discusses a Physics-Based Approach to Improving Therapeutic Delivery
Published: | Updated:
Laurent Levy, founder and CEO of Nanobiotix, discusses why physics-based therapeutics could complement traditional biology-driven drug development and explains how the company's NanoPrimer platform is designed to improve delivery of complex medicines.